Introduction
Waardenburg syndrome (WS) is a genetic condition that can produce facial, limb, and gastrointestinal anomalies along with varying degrees of sensorineural hearing loss. This syndrome was first identified in 1951, when a Dutch ophthalmologist reported the coexistence of pigment anomalies, eye anomalies, and hearing loss in some of his patients (Waardenburg, 1951). Since that time, four distinct types of WS have been identified based on phenotypic appearance and gene locus. WS affects an estimated 1 in 10,000 to 20,000 individuals in the general population (Read & Newton, 1997). Males and females are affected equally, as are all races and ethnic groups. WS is an interesting syndrome in that it is also found in animals such as splotch mice, horses, cats, and some specific breeds of dogs (Strain et al., 1992).
Some speech-language pathologists (SLPs) question their role in diagnosing and treating individuals with genetic syndromes or conditions, believing that these are solely the responsibilities of geneticists and physicians. Other SLPs have concerns about possible litigation resulting from referring individuals for genetic testing. Although diagnosis of specific genetic syndromes is not the responsibility of speech-language pathologists, it is the SLP's responsibility to be aware of genetic conditions that impact communication skills, to recognize patients who might be at risk for such conditions, to refer them for appropriate assessment and treatment, to treat the communication disorders associated with the syndrome, and to remain current in genetic information (Kahn, 2007). As Dr. Robert Shprintzen (1997) points out, SLPs are not qualified to render a genetic diagnosis, but they must, at the least, recognize that such a diagnosis may exist, and refer the patient for appropriate evaluation. This article describes SLP responsibilities and the major and minor characteristics of WS. It also suggests ways to recognize, refer, and treat individuals who may have this condition.
Responsibility #1: Recognizing Waardenburg Syndrome
Waardenburg syndrome results from early errors by a complex group of genes that are responsible for production, development, and distribution of melanocytes. Melanocytes produce pigment (melanin)which provides color to eyes, skin, and hair, as well as to the stria vascularis of the cochlea. Some, though not all, of these genes have been identified, although exactly when and how they interact with other genes to regulate melanocyte development is currently unknown (Hou & Pavan, 2008). The unusual appearance of skin, hair, and eyes of someone with WS results from genetic errors in production and distribution of melanocytes, and this appearance is easily visible to even casual observers. What is not readily visible is the condition of pigment cells in the cochlea. Sensorineural hearing loss has been hypothesized to result from abnormal migration of melanocytes, subsequently affecting the development of the stria vascularis in the cochlea (Toriello, Reardon & Gorlin, 2004). Individuals with some forms of WS may also have additional serious anomalies including cleft palate, anophthalmia, limb defects, and Hirschsprung's disease. Because pigment loss causes some very striking physical anomalies of the head and face, one might expect that individuals with WS would be immediately identified at birth. This is far from the case. SLPs routinely perform oral-facial examinations, and consequently are able to observe and identify individuals at risk for WS and refer them to the appropriate professionals for diagnosis and treatment. To do this, the anomalies associated with WS must first be recognized.
Phenotypic Signs of Waardenburg Syndrome
Four types of WS have been identified based on phenotypic appearance, gene location, and pattern of inheritance. The only absolutely accurate way of diagnosing a syndrome is through genetic testing, but genetic testing is not yet available for all types of WS. In such cases observing an individual's physical characteristics is helpful in making referral decisions. Identifying a pattern of physical features in an individual is called phenotyping. These features can be internal as well as external, and can include mental states, and normal as well as abnormal, physical appearance. All individuals have a phenotype. Your phenotype, for example, might be that you are tall, have red hair, blue eyes, hypoplastic kidneys, and fair skin.
Each of the four types of WS has a specific phenotype. Some phenotypes are major and some are minor. "Minor," when speaking of phenotypic features, is a relative term. Such anomalies are "minor" only in comparison to the major, sometimes life-threatening conditions. The major and minor phenotypic features of each type of WS are summarized in Table 1 and major features and some minor features are discussed following Table 1. However, for additional information and color photos of WS phenotypes visit: www.units.muohio.edu/waardenburgsyndrome/
Speech-Language Pathologists' Responsibilities Toward Individuals Who Have Waardenburg Syndrome
February 2, 2010
Share:
Related Courses
1
https://www.speechpathology.com/slp-ceus/course/ripple-effect-stuttering-community-based-9217
The Ripple Effect of Stuttering: A Community-Based Approach
This is Part 2 of a four-part series. The stuttering experience has a ripple effect that extends far beyond the child who stutters. Parents, teachers, peers, and others must possess both knowledge and skills to best support children who stutter. This course will highlight new clinical tools and resources to provide a community-based treatment approach for stuttering. (Part 1 - Course 9278, Part 3 - Course 9301, Part 4 - Course 9304)
auditory, textual, visual
129
USD
Subscription
Unlimited COURSE Access for $129/year
OnlineOnly
SpeechPathology.com
www.speechpathology.com
The Ripple Effect of Stuttering: A Community-Based Approach
This is Part 2 of a four-part series. The stuttering experience has a ripple effect that extends far beyond the child who stutters. Parents, teachers, peers, and others must possess both knowledge and skills to best support children who stutter. This course will highlight new clinical tools and resources to provide a community-based treatment approach for stuttering. (Part 1 - Course 9278, Part 3 - Course 9301, Part 4 - Course 9304)
9217
Online
PT120M
The Ripple Effect of Stuttering: A Community-Based Approach
Presented by Craig Coleman, MA, CCC-SLP, BCS-F, ASHA Fellow, Mary Weidner, PhD, CCC-SLP
Course: #9217Level: Intermediate2 Hours
ASHA/0.2 Intermediate, Professional; Calif SLPAB/2.0; IACET/0.2; Kansas LTS-S1370/2.0; SAC/2.0
This is Part 2 of a four-part series. The stuttering experience has a ripple effect that extends far beyond the child who stutters. Parents, teachers, peers, and others must possess both knowledge and skills to best support children who stutter. This course will highlight new clinical tools and resources to provide a community-based treatment approach for stuttering. (Part 1 - Course 9278, Part 3 - Course 9301, Part 4 - Course 9304)
2
https://www.speechpathology.com/slp-ceus/course/20q-infection-control-strategies-for-9729
20Q: Infection Control Strategies for SLPs
Speech-language pathologists are expected by policy authorities to apply appropriate measures to protect patients, co-workers and themselves in clinical situations that may expose individuals to infectious microbes. This article provides practical guidelines for implementing infection control principles within the context of the COVID-19 pandemic, including discussion of personal protective equipment (PPE) and disinfecting and cleaning products.
textual, visual
129
USD
Subscription
Unlimited COURSE Access for $129/year
OnlineOnly
SpeechPathology.com
www.speechpathology.com
20Q: Infection Control Strategies for SLPs
Speech-language pathologists are expected by policy authorities to apply appropriate measures to protect patients, co-workers and themselves in clinical situations that may expose individuals to infectious microbes. This article provides practical guidelines for implementing infection control principles within the context of the COVID-19 pandemic, including discussion of personal protective equipment (PPE) and disinfecting and cleaning products.
9729
Online
PT60M
20Q: Infection Control Strategies for SLPs
Presented by A.U. Bankaitis Smith, PhD
Course: #9729Level: Intermediate1 Hour
ASHA/0.1 Intermediate, Professional; Calif SLPAB/1.0; IACET/0.1; Kansas LTS-S1370/1.0; SAC/1.0
Speech-language pathologists are expected by policy authorities to apply appropriate measures to protect patients, co-workers and themselves in clinical situations that may expose individuals to infectious microbes. This article provides practical guidelines for implementing infection control principles within the context of the COVID-19 pandemic, including discussion of personal protective equipment (PPE) and disinfecting and cleaning products.
3
https://www.speechpathology.com/slp-ceus/course/thickened-liquids-in-clinical-practice-10497
Thickened Liquids in Clinical Practice: The Plot “Thickens”
Clinicians who utilize thickened liquids in their clinical practice are aware of their benefits, but what about the risks and contraindications? Advantages and disadvantages of thickened liquids are reviewed in this course with a focus on clinical outcomes, including impacts on medication administration, lung health, and hydration. Product types are evaluated to facilitate appropriate choices for individual clients.
auditory, textual, visual
129
USD
Subscription
Unlimited COURSE Access for $129/year
OnlineOnly
SpeechPathology.com
www.speechpathology.com
Thickened Liquids in Clinical Practice: The Plot “Thickens”
Clinicians who utilize thickened liquids in their clinical practice are aware of their benefits, but what about the risks and contraindications? Advantages and disadvantages of thickened liquids are reviewed in this course with a focus on clinical outcomes, including impacts on medication administration, lung health, and hydration. Product types are evaluated to facilitate appropriate choices for individual clients.
10497
Online
PT60M
Thickened Liquids in Clinical Practice: The Plot “Thickens”
Presented by Angela Mansolillo, MA, CCC-SLP, BCS-S
Course: #10497Level: Intermediate1 Hour
ASHA/0.1 Intermediate, Professional; Calif SLPAB/1.0; IACET/0.1; Kansas LTS-S1370/1.0; SAC/1.0
Clinicians who utilize thickened liquids in their clinical practice are aware of their benefits, but what about the risks and contraindications? Advantages and disadvantages of thickened liquids are reviewed in this course with a focus on clinical outcomes, including impacts on medication administration, lung health, and hydration. Product types are evaluated to facilitate appropriate choices for individual clients.
4
https://www.speechpathology.com/slp-ceus/course/slp-in-nicu-overview-11267
SLP in the NICU: An Overview
This course provides an introductory overview of Speech-Language Pathology services in the Neonatal Intensive Care Unit (NICU), including the unique environment, the SLP’s role, and key components of neonatal care. Topics include cue-based and supportive feeding strategies, instrumental assessments, and approaches for empowering and supporting parents and caregivers.
auditory, textual, visual
129
USD
Subscription
Unlimited COURSE Access for $129/year
OnlineOnly
SpeechPathology.com
www.speechpathology.com
SLP in the NICU: An Overview
This course provides an introductory overview of Speech-Language Pathology services in the Neonatal Intensive Care Unit (NICU), including the unique environment, the SLP’s role, and key components of neonatal care. Topics include cue-based and supportive feeding strategies, instrumental assessments, and approaches for empowering and supporting parents and caregivers.
11267
Online
PT60M
SLP in the NICU: An Overview
Presented by Anna Manilla, MS, CCC-SLP, CLC
Course: #11267Level: Introductory1 Hour
ASHA/0.1 Introductory, Professional; Calif SLPAB/1.0; IACET/0.1; IL EITP/1.0; Kansas LTS-S1370/1.0; SAC/1.0
This course provides an introductory overview of Speech-Language Pathology services in the Neonatal Intensive Care Unit (NICU), including the unique environment, the SLP’s role, and key components of neonatal care. Topics include cue-based and supportive feeding strategies, instrumental assessments, and approaches for empowering and supporting parents and caregivers.
5
https://www.speechpathology.com/slp-ceus/course/dysphagia-in-neurodegenerative-disease-9732
Dysphagia in Neurodegenerative Disease
Dysphagia is common in individuals with amyotrophic lateral sclerosis (ALS) and Parkinson’s disease. This course discusses the underlying pathophysiology and appropriate treatment programs for each disease, as well as use of alternate methods of nutrition/hydration.
auditory, textual, visual
129
USD
Subscription
Unlimited COURSE Access for $129/year
OnlineOnly
SpeechPathology.com
www.speechpathology.com
Dysphagia in Neurodegenerative Disease
Dysphagia is common in individuals with amyotrophic lateral sclerosis (ALS) and Parkinson’s disease. This course discusses the underlying pathophysiology and appropriate treatment programs for each disease, as well as use of alternate methods of nutrition/hydration.
9732
Online
PT60M
Dysphagia in Neurodegenerative Disease
Presented by Debra M. Suiter, PhD, CCC-SLP, BCS-S
Course: #9732Level: Intermediate1 Hour
ASHA/0.1 Intermediate, Professional; Calif SLPAB/1.0; IACET/0.1; Kansas LTS-S1370/1.0; SAC/1.0
Dysphagia is common in individuals with amyotrophic lateral sclerosis (ALS) and Parkinson’s disease. This course discusses the underlying pathophysiology and appropriate treatment programs for each disease, as well as use of alternate methods of nutrition/hydration.
